⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of CCS Associates, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
CCS Associates, Inc.
↗San Jose, California, USA
CCS Associates, Inc. (CCSA) is a woman-owned, full-service contract research organization (CRO) founded in 1985. The company provides scientific, technical, and regulatory advisory services to government agencies (notably the National Cancer Institute/NIH) and the pharmaceutical and biotechnology industries, supporting drug discovery and development from preclinical stages through to regulatory approval.
CCSA specializes in clinical trial management, regulatory affairs, bioinformatics, data management, and scientific writing. They are recognized for their expertise in managing complex clinical studies, including Master Protocols (such as the I-SPY 2 TRIAL), and providing strategic support for IND/NDA submissions and pharmacovigilance.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research & Regulatory Consulting
SIZE & FINANCIALS
Employees:51-200
Founded:1985
Ownership:private
Status:operating
PIPELINE
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:National Cancer Institute (NCI), National Institutes of Health (NIH)
COMPETITION
Position:Niche Player
Competitors:Charles River Laboratories, IQVIA, PPD, Parexel
LEADERSHIP
Key Executives:
Caroline C. Sigman - President and CEO
Donya Bagheri - Executive Director, Research and Development
Scientific Founders:Caroline C. Sigman
LINKS
Website:ccsainc.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CCS Associates, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.